![]() | Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., Journe, F., & Carlier, S. (19 October 2022). Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells. International Journal of Molecular Sciences, 23 (20), 12552. doi:10.3390/ijms232012552 ![]() |
Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., & Carlier, S. (10 February 2022). Development of 'home-made' oxLDL to study the interplay between atherosclerosis and cancer: characterization of their effects on head and neck cancer cells. Paper presented at Belgian Society of Cardiology Meeting, Bruxelles, Belgium. |
Gheysen, L., Soumoy, L., Trelcat, A., Verset, L., Journe, F., & Saussez, S. (2021). New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer. Cells. |
![]() | Kindt, N., Journe, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (05 May 2021). Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas. Biomedicines, 9 ((5)), 513. |
Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journe, F., & Saussez, S. (2020). ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology. |
Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies. Poster session presented at 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium. doi:10.1088/1748-0221/5/03/T03014 |
Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies. Poster session presented at BACR Annual meeting, Jette, Belgium. |
Gheysen, L., Descamps, G., Seminerio, I., Furgiuele, S., Soumoy, L., & Trelcat, A. (2019). Wonder Researchers , Communication audiovisuelle, Journée des doctorants, Mons, 2019. |